Drug review: Carfilzomib
Carfilzomib is a second generation proteasome inhibitor approved for use in relapsed/ refractory multiple myeloma. The mechanism of action, usage, toxicity and key trials involving this agent are briefly reviewed here.
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2019-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=1;spage=130;epage=131;aulast=Ganesan |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850104955480834048 |
|---|---|
| author | Prasanth Ganesan |
| author_facet | Prasanth Ganesan |
| author_sort | Prasanth Ganesan |
| collection | DOAJ |
| description | Carfilzomib is a second generation proteasome inhibitor approved for use in relapsed/ refractory multiple myeloma. The mechanism of action, usage, toxicity and key trials involving this agent are briefly reviewed here. |
| format | Article |
| id | doaj-art-40b6ca00a8214b2eadc539ab64641624 |
| institution | DOAJ |
| issn | 0971-5851 0975-2129 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-40b6ca00a8214b2eadc539ab646416242025-08-20T02:39:13ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58510975-21292019-01-0140113013110.4103/ijmpo.ijmpo_67_19Drug review: CarfilzomibPrasanth GanesanCarfilzomib is a second generation proteasome inhibitor approved for use in relapsed/ refractory multiple myeloma. The mechanism of action, usage, toxicity and key trials involving this agent are briefly reviewed here.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=1;spage=130;epage=131;aulast=GanesanCarfilzomibproteasome inhibitormultiple myeloma |
| spellingShingle | Prasanth Ganesan Drug review: Carfilzomib Indian Journal of Medical and Paediatric Oncology Carfilzomib proteasome inhibitor multiple myeloma |
| title | Drug review: Carfilzomib |
| title_full | Drug review: Carfilzomib |
| title_fullStr | Drug review: Carfilzomib |
| title_full_unstemmed | Drug review: Carfilzomib |
| title_short | Drug review: Carfilzomib |
| title_sort | drug review carfilzomib |
| topic | Carfilzomib proteasome inhibitor multiple myeloma |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=1;spage=130;epage=131;aulast=Ganesan |
| work_keys_str_mv | AT prasanthganesan drugreviewcarfilzomib |